Risk factors, management, and future fertility of empty follicle syndrome: a retrospective study with real-world data

被引:0
|
作者
Luo, Zhuoye [1 ,2 ,3 ,4 ]
Xu, Suxin [1 ,2 ,3 ,4 ]
Hao, Guimin [1 ,2 ,3 ,4 ]
机构
[1] Hebei Med Univ, Dept Reprod Med, Hosp 2, Shijiazhuang, Peoples R China
[2] Hebei Ctr Qual Control & Management Human Assisted, Shijiazhuang, Peoples R China
[3] Hebei Key Lab Infertil & Hered, Shijiazhuang, Peoples R China
[4] Hebei Clin Res Ctr Birth Defects, Shijiazhuang, Peoples R China
来源
关键词
empty follicle syndrome; oocyte trigger; hCG exposure time; polycystic ovary syndrome; cumulative live birth rate; IN-VIVO; MATURATION; HCG; INTERVAL; PREVALENCE; GENE;
D O I
10.3389/fendo.2024.1424837
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Empty follicle syndrome (EFS) is a challenging clinical problem. This study aims to identify the risk factors for EFS, to present pregnancy outcomes in both EFS cycle as well as subsequent cycles, and to summarize an effective rescue protocol to improve outcomes. Methods: A retrospective analysis between 2016 and 2020 was conducted at our center. Stricter criteria were applied to diagnose EFS. Logistic regression analysis was used to identify the risk factors for EFS. Further analyses were performed within the EFS cycle to present pregnancy outcomes and to find optimal rescue protocols. Long-term follow-up was conducted until live birth was achieved, covering at least two complete oocyte retrieval cycles. Results: Among 14,066 patients, 54 (0.38%) were identified as EFS. Patients with polycystic ovary syndrome (PCOS) had a significantly higher risk of developing EFS than non-PCOS ones (aOR = 2.67; 95% CI, 1.47 to 4.83). Within EFS patients, delaying the second oocyte retrieval by 3-6 h significantly improved the rates of obtaining oocyte (97.4% versus 58.3%, P = 0.002), getting embryo available for transfer (92.3% versus 33.3%, P < 0.001), and pregnancy (48.7% versus 8.3%, P = 0.017) compared to other delayed retrieval times. Overall, 31.5% (17/54) and 46.7% (7/15) EFS patients achieved live birth in the EFS cycle and the future cycle, respectively. Conclusions: PCOS is an independent risk factor for EFS, indicating that longer exposure time to human chorionic gonadotropin (hCG) may be necessary. Delaying the second oocyte retrieval by 3-6 h is an effective rescue protocol for EFS patients to achieve optimal outcomes. EFS in a single cycle does not necessarily indicate future fertility decline, but repeated EFS may result in poor outcomes.
引用
收藏
页数:9
相关论文
共 50 条
  • [21] Epidemiology and risk factors associated with gout control among adult Asians: a real-world retrospective cohort study
    Oka, Prawira
    Chong, Wei Ming
    Ng, Ding Xuan
    Aau, Wai Keong
    Tan, Ngiap Chuan
    FRONTIERS IN MEDICINE, 2023, 10
  • [22] RCC Real-World Data: Prognostic Factors and Risk Stratification in the Immunotherapy Era
    Sagie, Shira
    Sarfaty, Michal
    Levartovsky, Meital
    Sorotsky, Hadas Gantz
    Berger, Raanan
    Percik, Ruth
    Gadot, Moran
    CANCERS, 2022, 14 (13)
  • [23] Abscopal Response in Metastatic Melanoma: Real-World Data of a Retrospective, Multicenter Study
    Ollivier, Luc
    Orione, Charles
    Bore, Paul
    Misery, Laurent
    Legoupil, Delphine
    Leclere, Jean-Christophe
    Coste, Anne
    Girault, Gilles
    Sicard-Cras, Iona
    Kacperek, Clemence
    Lucia, Francois
    Stefan, Dinu
    Thillays, Francois
    Rio, Emmanuel
    Lesueur, Paul
    Berthou, Christian
    Heymann, Dominique
    Champiat, Stephane
    Supiot, Stephane
    Vaugier, Loig
    CANCERS, 2022, 14 (17)
  • [24] Anlotinib for Metastatic Progressed Pheochromocytoma and Paraganglioma: A Retrospective Study of Real-World Data
    Tian, Rui
    Yao, Xiaochen
    Song, Jieping
    Wang, Jun
    Fu, Jingjing
    Shi, Liang
    Yu, Fei
    Zhang, Pengjun
    Zhang, Chuan
    Ni, Yudan
    Wang, Feng
    JOURNAL OF THE ENDOCRINE SOCIETY, 2024, 8 (06)
  • [25] Methodological Concerns Regarding a Retrospective Study With Real-World Data on Paxlovid in Israel
    Uchikoba, Sana
    Yamada, Gen
    Tsuzuki, Shinya
    CLINICAL INFECTIOUS DISEASES, 2022, 75 (12)
  • [26] Real-World Data for Lenvatinib in Hepatocellular Carcinoma (ELEVATOR): A Retrospective Multicenter Study
    Welland, Sabrina
    Leyh, Catherine
    Finkelmeier, Fabian
    Jefremow, Andre
    Shmanko, Kateryna
    Gonzalez-Carmona, Maria A.
    Kandulski, Arne
    Jeliazkova, Petia
    Best, Jan
    Fruendt, Thorben W.
    Djanani, Angela
    Pangerl, Maria
    Maieron, Andreas
    Greil, Richard
    Fricke, Christina
    Sookthai, Disorn
    Guenther, Rainer
    Schmiderer, Andreas
    Wege, Henning
    Venerito, Marino
    Ehmer, Ursula
    Mueller, Martina
    Strassburg, Christian P.
    Weinmann, Arndt
    Siebler, Jurgen
    Waidmann, Oliver
    Lange, Christian M.
    Saborowski, Anna
    Vogel, Arndt
    LIVER CANCER, 2022, 11 (03) : 219 - 232
  • [27] A model for data monitoring committees for retrospective study designs in the real-world setting
    Major-Pedersen, Atheline
    McCullen, Mary Kate
    Sabol, Mary Beth
    Adetunji, Omolara
    Massaro, Joseph
    Neugut, Alfred
    Sosa, Julie Ann
    Hollenberg, Anthony
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2018, 27 : 259 - 259
  • [28] Analysis of risk factors for immune checkpoint inhibitor-associated liver injury: a retrospective analysis based on clinical study and real-world data
    Wang, Bitao
    Zhuang, Shaowei
    Lin, Shengnan
    Lin, Jierong
    Zeng, Wanxian
    Du, Bin
    Yang, Jing
    HEPATOLOGY INTERNATIONAL, 2025,
  • [29] The dynamic risk factors of cardiovascular disease among people living with HIV: a real-world data study
    Liu, Ziang
    Zhang, Jiajia
    Yang, Xueying
    Gao, Haoyuan
    Chen, Shujie
    Weissman, Sharon
    Olatosi, Bankole
    Li, Xiaoming
    BMC PUBLIC HEALTH, 2024, 24 (01)
  • [30] Children with appendectomy have increased risk of future sepsis: Real-world data in Taiwan
    Liao, Tzu-Han
    Lin, Cheng-Li
    Lin, Chien-Heng
    Wu, Meng-Che
    Wei, James Cheng-Chung
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2021, 75 (12)